Stocks within Investors Radar: Tantech Holdings Ltd (TANH), Bellicum Pharmaceuticals, Inc. (BLCM)

Tantech Holdings Ltd (TANH):

Last Trade:

Tantech Holdings Ltd (TANH) ended its previous trading session at $2.99 with the Gain of 1.01%. The company’s market cap is $88.38 Million, and the average volume is $669.49 Million. The 52-Week High range of the stock is $4.54, while the 52-week low range is $1.26. The Price to Sales (P/S) of the stock is 1.85, while P/B (Price to Book) stands at 0.89. When we look at the Volatility of the company, Week Volatility is at 5.73% whereas Month Volatility is at 4.03%.

Tantech Holdings Ltd (TANH) analysts on average have given a price target of $0 on TANH stock.

Bellicum Pharmaceuticals, Inc. (BLCM):

Previous Trade:

Bellicum Pharmaceuticals, Inc. (BLCM) shares declined -0.11% and ended the day at $8.97. Its 52-week high and low range is between $14.49 and $5.02. The company’s outstanding shares are 30.8 Million. The volume of the company in the last trading session was 857242. The stock has a market cap of 276.28 Million. The Stock shows P/E value of 0 and Forward P/E of 0.

According to Finviz reported data, The SMA20 of the stock is at 24.01%, SMA50 is 27.96 percent, while SMA200 is -2.94%. The stock is currently has its Return on Assets (ROA) value of -57.4 Percent. The Return on Investment and Return on Equity (ROE) values are -74.5 percent and -80.9 percent, respectively.

The company’s ATR (Average True Range) is 0.57. The Weekly Volatility is 9.57% and the Monthly Volatility is 6.94%.

When we look at the Analyst Recommendations of the stock, the company has 1.17 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell.

Bellicum Pharmaceuticals, Inc. (BLCM) analysts on average have given a price target of $0 on BLCM stock.

Bellicum Pharmaceuticals, Inc.’s Average Earnings Estimate for the current quarter is $-0.69, according to consensus of 8 analysts. The low EPS estimate is $-0.84, while the high EPS estimate is $-0.61.

Average Revenue Estimate of the company for the current Fiscal Quarter is $30000, according to consensus of 7 analysts. The higher end of the revenue estimate is $100000 and the lower end is $0.